| 000 | 01820 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517010542.0 | ||
| 264 | 0 | _c20160217 | |
| 008 | 201602s 0 0 eng d | ||
| 022 | _a1931-8448 | ||
| 024 | 7 |
_a10.1089/mdr.2014.0075 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMohajeri, Parviz | |
| 245 | 0 | 0 |
_aFrequency of Mutations Associated with Rifampicin Resistance in Mycobacterium tuberculosis Strains Isolated from Patients in West of Iran. _h[electronic resource] |
| 260 |
_bMicrobial drug resistance (Larchmont, N.Y.) _cJun 2015 |
||
| 300 |
_a315-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntitubercular Agents _xpharmacology |
| 650 | 0 | 4 |
_aBacterial Proteins _xgenetics |
| 650 | 0 | 4 | _aCodon |
| 650 | 0 | 4 | _aDNA-Directed RNA Polymerases |
| 650 | 0 | 4 |
_aDrug Resistance, Bacterial _xgenetics |
| 650 | 0 | 4 |
_aExtensively Drug-Resistant Tuberculosis _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Expression |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 |
_aIran _xepidemiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMutation Rate |
| 650 | 0 | 4 |
_aMycobacterium tuberculosis _xdrug effects |
| 650 | 0 | 4 | _aOligonucleotide Array Sequence Analysis |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 |
_aRifampin _xpharmacology |
| 650 | 0 | 4 |
_aSputum _xmicrobiology |
| 650 | 0 | 4 |
_aTuberculosis, Pulmonary _xdrug therapy |
| 700 | 1 | _aSadri, Hadis | |
| 700 | 1 | _aFarahani, Abbas | |
| 700 | 1 | _aNorozi, Baharak | |
| 700 | 1 | _aAtashi, Sara | |
| 773 | 0 |
_tMicrobial drug resistance (Larchmont, N.Y.) _gvol. 21 _gno. 3 _gp. 315-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/mdr.2014.0075 _zAvailable from publisher's website |
| 999 |
_c24474496 _d24474496 |
||